Neurotropin
Sponsors
Department of Obstetrics and Gynecology, The University of Tokushima, National Institute of Nursing Research (NINR), VanWorld Pharmaceutical (Rugao) Company Limited, Sun Yat-sen University
Conditions
Colorectal CancerComplex Regional Pain Syndrome Type IComplex Regional Pain Syndrome Type IIFibromyalgiaLow Back PainNeuropathic PainThe patient of gynecologic cancer treated with paclitaxel
Phase 2
Neurotropin to Treat Chronic Neuropathic Pain
TerminatedNCT00006289
Start: 2000-09-30End: 2012-06-30Updated: 2017-08-22
Neurotropin Treatment of Fibromyalgia
CompletedNCT00366535
Start: 2006-08-31End: 2015-12-31Updated: 2018-06-27
Investigation of preventive effect with neurotropin for neuropathy due to paclitaxel
Active, not recruitingJPRN-UMIN000012211
Start: 2014-01-01Target: 50Updated: 2026-06-29
Phase 3
Analgecine for Treatment of Low Back Pain
CompletedNCT02168010
Start: 2013-10-31End: 2014-07-31Updated: 2015-12-09
Analgecine for the Treatment of Neuropathic Pain
CompletedNCT02633618
Start: 2005-08-31End: 2005-12-31Updated: 2015-12-17
Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients
CompletedNCT07320950
Start: 2022-04-01End: 2025-12-22Updated: 2026-01-06